000788 北大医药
已收盘 12-12 15:00:00
资讯
新帖
简况
北大医药(000788.SZ)取得阿普米司特片药品注册证书
智通财经 · 09-25
北大医药(000788.SZ)取得阿普米司特片药品注册证书
北大医药(000788)披露公司治理结构调整及董事会人员补选结果,9月19日股价下跌1.3%
证券之星 · 09-19
北大医药(000788)披露公司治理结构调整及董事会人员补选结果,9月19日股价下跌1.3%
北大医药最新公告:向首都医科大学教育基金会捐赠300万元用于医学教育科研事业
证券之星 · 09-18
北大医药最新公告:向首都医科大学教育基金会捐赠300万元用于医学教育科研事业
9月12日增减持汇总:北大医药等18家公司减持 当日暂无A股增持(表)
新浪证券 · 09-12
9月12日增减持汇总:北大医药等18家公司减持 当日暂无A股增持(表)
北大医药股东计划在10月14日至2026年1月11日期间减持最多3%股份
美股速递 · 09-12
北大医药股东计划在10月14日至2026年1月11日期间减持最多3%股份
北大医药最新公告:北大医疗拟减持3%股份
证券之星 · 09-12
北大医药最新公告:北大医疗拟减持3%股份
北大医药:已启动公司及相关子公司名称变更工作
证券之星 · 08-28
北大医药:已启动公司及相关子公司名称变更工作
北大医药:镇痛类产品包括萘丁美酮胶囊、塞来昔布胶囊等
证券之星 · 08-28
北大医药:镇痛类产品包括萘丁美酮胶囊、塞来昔布胶囊等
北大医药:主营化学仿制药制剂研发生产销售及医药流通业务,重点聚焦抗感染等四大核心领域
金融界 · 08-28
北大医药:主营化学仿制药制剂研发生产销售及医药流通业务,重点聚焦抗感染等四大核心领域
北大医药:2025年上半年净利润1亿元,同比增长15.51%
金融界 · 08-21
北大医药:2025年上半年净利润1亿元,同比增长15.51%
北大医药:公司新的战略尚待进一步探索和落地
证券之星 · 08-13
北大医药:公司新的战略尚待进一步探索和落地
8月12日北大医药(000788)龙虎榜数据:机构净买入753.37万元
证券之星 · 08-12
8月12日北大医药(000788)龙虎榜数据:机构净买入753.37万元
北大医药最新公告:与北京大学国际医院业务合作终止后面临主营业务全面中止风险
证券之星 · 08-11
北大医药最新公告:与北京大学国际医院业务合作终止后面临主营业务全面中止风险
北大医药(000788.SZ)拟以公司生产制造中心为基础组建生产制造子公司
智通财经 · 08-08
北大医药(000788.SZ)拟以公司生产制造中心为基础组建生产制造子公司
北大医药最新公告:拟启动公司及相关子公司名称变更工作 实现“去北大化”
证券之星 · 08-08
北大医药最新公告:拟启动公司及相关子公司名称变更工作 实现“去北大化”
北大医药:截至2025年7月31日股东总户数为53,416户
证券之星 · 08-07
北大医药:截至2025年7月31日股东总户数为53,416户
北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务
证券之星 · 07-04
北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务
北大医药(000788.SZ)拟出资500万元发起设立公益基金会
智通财经 · 07-04
北大医药(000788.SZ)拟出资500万元发起设立公益基金会
小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆
北大医药 · 06-25
小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆
北大医药:关于公司董事兼总裁辞职的公告
新浪财经-鹰眼工作室 · 06-24
北大医药:关于公司董事兼总裁辞职的公告
加载更多
公司概况
公司名称:
北大医药股份有限公司
所属行业:
医药制造业
上市日期:
1997-06-16
主营业务:
北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、奥氮平片盐酸丁螺环酮片、右酮洛芬胶囊右酮洛芬片、塞来昔布胶囊。公司是国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。
发行价格:
5.70
{"stockData":{"symbol":"000788","market":"SZ","secType":"STK","nameCN":"北大医药","latestPrice":6.42,"timestamp":1765522992000,"preClose":6.57,"halted":0,"volume":33010291,"delay":0,"changeRate":-0.0228,"floatShares":596000000,"shares":596000000,"eps":0.241,"marketStatus":"已收盘","change":-0.15,"latestTime":"12-12 15:00:00","open":6.56,"high":6.59,"low":6.41,"amount":213000000,"amplitude":0.0274,"askPrice":6.43,"askSize":674,"bidPrice":6.42,"bidSize":2733,"shortable":0,"etf":0,"ttmEps":0.241,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.57,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":7.23,"lowLimit":5.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":595987425,"isCdr":false,"pbRate":2.42,"roa":"--","peRate":26.639004,"roe":"8.63%","epsLYR":0.2315,"committee":0.569453,"marketValue":3826000000,"turnoverRate":0.0554,"status":1,"floatMarketCap":3826000000},"requestUrl":"/m/hq/s/000788?page=2","defaultTab":"news","newsList":[{"id":"2570932062","title":"北大医药(000788.SZ)取得阿普米司特片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2570932062","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570932062?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:41","pubTimestamp":1758789669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)公告,公司收到国家药品监督管理局核准签发的《药品注册证书》,本次取得药品注册证书的药品为阿普米司特片两种规格(10mg与30mg)。阿普米司特是一种特异性靶向磷酸二酯酶-4(PDE4)的小分子抑制剂,通过调节细胞内炎症信号通路,有效抑制促炎因子释放并增加抗炎因子生成,从而精准控制炎症反应。阿普米司特片用于治疗符合接受光疗或系统治疗指征的中度至重度斑块状银屑病的成人患者,具有起效快、疗效明确、安全性高等特点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"北大医药(000788.SZ)取得阿普米司特片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","BK0122","BK0239","BK0028","000788","BK0012","BK0060","BK0096"],"gpt_icon":0},{"id":"2568591502","title":"北大医药(000788)披露公司治理结构调整及董事会人员补选结果,9月19日股价下跌1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568591502","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568591502?lang=zh_cn&edition=full","pubTime":"2025-09-19 17:21","pubTimestamp":1758273673,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,北大医药报收于6.07元,较前一交易日下跌1.3%,最新总市值为36.18亿元。该股当日开盘6.15元,最高6.16元,最低6.04元,成交额达7075.75万元,换手率为1.95%。根据近日发布的《2025年第三次临时股东大会决议公告》,北大医药于2025年9月18日召开第三次临时股东大会,会议审议通过了多项议案。本次股东大会采用现场与网络投票相结合的方式举行,出席股东及授权代表共261人,代表股份213,018,095股,占公司有表决权股份总数的35.7420%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900026142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788","BK0028","BK0060","BK0096","BK0102","BK0122","BK0239","000860.SH","BK0012"],"gpt_icon":0},{"id":"2568470626","title":"北大医药最新公告:向首都医科大学教育基金会捐赠300万元用于医学教育科研事业","url":"https://stock-news.laohu8.com/highlight/detail?id=2568470626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568470626?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:01","pubTimestamp":1758200482,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司第十一届董事会第十五次会议审议通过向首都医科大学教育基金会捐赠300万元,用于支持首都医科大学肿瘤学系人才培养、医学科研等事项。该捐赠不属于关联交易,不构成重大资产重组,无需提交股东会审议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800035722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0122","000788","BK0060","BK0012","BK0102","BK0239"],"gpt_icon":0},{"id":"2566972447","title":"9月12日增减持汇总:北大医药等18家公司减持 当日暂无A股增持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566972447","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566972447?lang=zh_cn&edition=full","pubTime":"2025-09-12 21:34","pubTimestamp":1757684040,"startTime":"0","endTime":"0","summary":"控股股东的一致行动人拟减持不超过2.94%. 股东徐小强9月1日至9月12日期间累计减持129.61万股。深创投及其一致行动人拟减持不超过3%公司股份。投资者据此操作,风险自担。海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-09-12/doc-infqhchz7337130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000788","399300","BK0102","BK0012","BK0239","BK0122","BK0028","BK0096","159982","BK0060"],"gpt_icon":0},{"id":"1193475952","title":"北大医药股东计划在10月14日至2026年1月11日期间减持最多3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1193475952","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193475952?lang=zh_cn&edition=full","pubTime":"2025-09-12 20:40","pubTimestamp":1757680828,"startTime":"0","endTime":"0","summary":"北大医药公告称,公司股东计划在2025年10月14日至2026年1月11日期间减持最多3%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000788","BK0122","BK0060","BK0012","BK0096","BK0239","BK0102","BK0028"],"gpt_icon":0},{"id":"2566433971","title":"北大医药最新公告:北大医疗拟减持3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2566433971","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566433971?lang=zh_cn&edition=full","pubTime":"2025-09-12 20:39","pubTimestamp":1757680771,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,持股11.80%的股东北大医疗计划自2025年10月14日至2026年1月11日,以集中竞价和大宗交易方式合计减持不超过1787.96万股,占公司总股本3%。其中,通过集中竞价方式减持不超595.99万股,占1%;通过大宗交易方式减持不超1191.97万股,占2%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200035017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000788","BK0102","BK0028","BK0060","159891","BK0122","BK0239","BK0012"],"gpt_icon":0},{"id":"2562897220","title":"北大医药:已启动公司及相关子公司名称变更工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2562897220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562897220?lang=zh_cn&edition=full","pubTime":"2025-08-28 16:36","pubTimestamp":1756370169,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药08月28日在投资者关系平台上答复投资者关心的问题。投资者提问:变更实控人已经8个月,公司依旧还用着北大的名字忽悠投资者。请公司尽快改名,停止欺骗行为北大医药回复:投资者您好!公司于2025年8月8日召开第十一届董事会第十二次会议审议通过了《关于启动公司及相关子公司名称变更工作的议案》,公司已逐步启动公司及相关子公司名称变更工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800030738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0012","000788","BK0102","BK0122","BK0028","BK0096","BK0239"],"gpt_icon":0},{"id":"2562089591","title":"北大医药:镇痛类产品包括萘丁美酮胶囊、塞来昔布胶囊等","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562089591?lang=zh_cn&edition=full","pubTime":"2025-08-28 16:30","pubTimestamp":1756369832,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药08月28日在投资者关系平台上答复投资者关心的问题。公司医药制造板块产品目前重点聚焦于抗感染类、镇痛类、精神类、慢病类核心领域,其中镇痛类产品主要包括萘丁美酮胶囊、塞来昔布胶囊、右酮洛芬片、右酮洛芬胶囊。关于公司的主要产品可参见公司在巨潮资讯网披露的定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800030559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000788","BK0102","BK0012","BK0028","BK0096","BK0122"],"gpt_icon":0},{"id":"2562772647","title":"北大医药:主营化学仿制药制剂研发生产销售及医药流通业务,重点聚焦抗感染等四大核心领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2562772647","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562772647?lang=zh_cn&edition=full","pubTime":"2025-08-28 08:41","pubTimestamp":1756341704,"startTime":"0","endTime":"0","summary":"金融界8月28日消息,有投资者在互动平台向北大医药提问:“蚂蚁集团推出AI健康应用AQ,连接全国超5000家医院和近百万医生,整合血糖、睡眠等健康数据提供个性化建议。请问公司能够从哪方面提供帮助?”","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28084152761475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0096","BK0102","BK0028","BK0012","159938","000788","BK0122","BK0060","BK1515","BK1574","09939","BK0239","BK1161"],"gpt_icon":0},{"id":"2561649624","title":"北大医药:2025年上半年净利润1亿元,同比增长15.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561649624","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561649624?lang=zh_cn&edition=full","pubTime":"2025-08-21 19:24","pubTimestamp":1755775476,"startTime":"0","endTime":"0","summary":"北大医药公告,2025年上半年营业收入9.57亿元,同比下降5.04%。净利润1亿元,同比增长15.51%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/21192452594306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000788"],"gpt_icon":0},{"id":"2559281602","title":"北大医药:公司新的战略尚待进一步探索和落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2559281602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559281602?lang=zh_cn&edition=full","pubTime":"2025-08-13 20:51","pubTimestamp":1755089499,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:作为一家上市28年的公司,对内压降员工薪酬福利,对外不维护中小投资者利益。请问这样的公司 还有生存的价值吗北大医药回复:投资者您好!客观来讲,大股东变更对上市公司的发展战略影响巨大,公司目前新的战略尚待进一步探索和落地。公司近年来业绩稳健增长,员工的收入和获得感也在不断提升。感谢您对北大医药的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081300036614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0122","000788","BK0060","BK0028","BK0096","BK0102"],"gpt_icon":0},{"id":"2558643854","title":"8月12日北大医药(000788)龙虎榜数据:机构净买入753.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558643854?lang=zh_cn&edition=full","pubTime":"2025-08-12 17:19","pubTimestamp":1754990349,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年8月12日公布的交易公开信息显示,北大医药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年8月12日收盘,北大医药报收于6.42元,下跌7.36%,换手率11.13%,成交量66.32万手,成交额4.26亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入753.37万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200029387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","000788","BK0239","BK0060","BK0028","BK0102","BK0122","BK0096"],"gpt_icon":0},{"id":"2558047656","title":"北大医药最新公告:与北京大学国际医院业务合作终止后面临主营业务全面中止风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2558047656","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558047656?lang=zh_cn&edition=full","pubTime":"2025-08-11 18:09","pubTimestamp":1754906999,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司全资子公司北京北医医药与北京大学国际医院的长期服务合同即将到期,双方决定在2025年5月终止业务合作。由于北医医药的主营业务高度依赖与国际医院的合作,预计将导致公司2025年销售收入减少约6亿元,净利润减少约4,000万元。2026年起可能面临营业收入减少约10.27亿元,净利润减少约6,869万元的风险。公司正在探索北医医药转型新方向,但存在不确定性。若转型失败,公司可能面临关停并转风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100031207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000788","BK0096","BK0102","BK0012","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2557528479","title":"北大医药(000788.SZ)拟以公司生产制造中心为基础组建生产制造子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2557528479","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557528479?lang=zh_cn&edition=full","pubTime":"2025-08-08 18:32","pubTimestamp":1754649173,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)公告,公司拟对公司现有生产制造体系进行战略性调整,并提请公司股东大会授权董事会以公司位于重庆市北碚区水土镇工业园区(简称“水土工业园区”)的生产制造中心为基础,组建生产制造子公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","BK0028","BK0239","BK0122","BK0012","BK0060","000788","BK0096"],"gpt_icon":0},{"id":"2557540934","title":"北大医药最新公告:拟启动公司及相关子公司名称变更工作 实现“去北大化”","url":"https://stock-news.laohu8.com/highlight/detail?id=2557540934","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557540934?lang=zh_cn&edition=full","pubTime":"2025-08-08 18:00","pubTimestamp":1754647209,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司第十一届董事会第十二次会议于8月8日召开,会议审议通过了《关于启动公司及相关子公司名称变更工作的议案》。公司实际控制人已变更为徐晰人,且与北京大学无股权关系。为明确上市公司目前的控股关系,并根据经营及业务发展需要,公司拟逐步完成相关名称变更工作,实现“去北大化”。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080800030900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0060","000788","BK0102","BK0122","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2557532465","title":"北大医药:截至2025年7月31日股东总户数为53,416户","url":"https://stock-news.laohu8.com/highlight/detail?id=2557532465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557532465?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:48","pubTimestamp":1754552895,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药(000788)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2025年7月31日公司股东人数是多少?谢谢~北大医药回复:投资者您好!截止至2025年7月31日,公司股东总户数为53,416户。感谢您对北大医药的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700022407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0028","BK0102","BK0060","BK0122","000788","BK0239"],"gpt_icon":0},{"id":"2548236103","title":"北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2548236103","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548236103?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:11","pubTimestamp":1751620267,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司全资子公司新优势(重庆)健康产业发展有限公司拟运用自有资金,使用独立的自营账户,开展场内股票、债券投资,投资总额度不超过公司最近一期经审计净资产的10%。投资目的是积极响应“活跃资本市场,提振投资者信心”的工作规划,探索丰富的盈利和投资模式,推动企业经营质量与资本价值的良性互动。证券投资存在宏观经济、行业周期、财政及货币政策等多种因素影响,以及相关工作人员的操作风险,收益具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400027094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0060","BK0122","161027","000788","BK0102","BK0028","BK0239"],"gpt_icon":0},{"id":"2548369049","title":"北大医药(000788.SZ)拟出资500万元发起设立公益基金会","url":"https://stock-news.laohu8.com/highlight/detail?id=2548369049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548369049?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:04","pubTimestamp":1751619867,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)发布公告,公司秉持可持续发展理念,积极支持公益慈善事业。公司为响应国家“健康中国2030”战略,弥补医疗健康领域公益资源缺口,整合医疗健康行业(药企、医疗机构、科研单位等)资源,推动普惠医疗、贫困救助、医药医疗科研创新等,同时也为加强公司公益事业的规划和管理,更好履行作为公众公司的社会责任,持续提升公司品牌的影响力,公司拟出资人民币500万元发起设立公益基金会。公司本次拟捐赠500万元人民币并设立重庆建渝基金会,其核心目标是通过公益慈善推动医疗健康公平,重点覆盖弱势群体(如低收入患者、罕见病患者、偏远地区医疗援助等)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0012","BK0028","BK0239","000788","BK0122","BK0096","BK0102"],"gpt_icon":0},{"id":"2546269817","title":"小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2546269817","media":"北大医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546269817?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:48","pubTimestamp":1750819731,"startTime":"0","endTime":"0","summary":"为紧跟药品零售终端日渐增长行业趋势,践行北大医药“双轮驱动”营销战略,加速拓展院外市场,近期,北大医药与云南健之佳达成深度战略合作,以公司抗炎镇痛核心产品右酮洛芬胶囊为切入点,共同探索创新合作模式,开启KA连锁标杆合作新篇章。此次战略携手,是北大医药应对行业变革、探索营销新模式的主动布局,更是践行“以患者为中心”理念的深度实践。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625111841a71c3e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625111841a71c3e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000788","BK0122","BK0060","BK0012","605266","BK0209","BK0096","BK0239","BK0102","BK0028"],"gpt_icon":0},{"id":"2545284847","title":"北大医药:关于公司董事兼总裁辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284847","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545284847?lang=zh_cn&edition=full","pubTime":"2025-06-24 19:40","pubTimestamp":1750765200,"startTime":"0","endTime":"0","summary":"北大医药股份有限公司关于公司董事兼总裁辞职的公告北大医药股份有限公司董事会于近日收到董事兼总裁袁平东先生的书面辞职报告。袁平东先生因个人原因申请辞去公司董事、总裁职务,同时辞去董事会战略委员会委员职务,且不再担任公司任何职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-06-24/doc-infcerue8901458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","BK0239","BK0012","BK0096","BK0028","000788","BK0060","BK0102"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765734624110,"stockEarnings":[{"period":"1week","weight":-0.1265},{"period":"1month","weight":-0.0389},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0837},{"period":"1year","weight":-0.0383},{"period":"ytd","weight":0.0803}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北大医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49362人(较上一季度减少2.88%)","perCapita":"12073股","listingDate":"1997-06-16","address":"重庆市北碚区水土镇方正大道21号","registeredCapital":"59598万元","survey":" 北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、奥氮平片盐酸丁螺环酮片、右酮洛芬胶囊右酮洛芬片、塞来昔布胶囊。公司是国家创新型试点企业、国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业、重庆市专精特新企业、重庆市制造业百强企业。","listedPrice":5.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北大医药,000788,北大医药股票,北大医药股票老虎,北大医药股票老虎国际,北大医药行情,北大医药股票行情,北大医药股价,北大医药股市,北大医药股票价格,北大医药股票交易,北大医药股票购买,北大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}